| 000 | 01585 a2200481 4500 | ||
|---|---|---|---|
| 005 | 20250513133831.0 | ||
| 264 | 0 | _c19980227 | |
| 008 | 199802s 0 0 eng d | ||
| 022 | _a0009-3157 | ||
| 024 | 7 |
_a10.1159/000007086 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aOzaki, M | |
| 245 | 0 | 0 |
_aIn vivo antibacterial activity of a prodrug of NM394, a thiazetoquinoline carboxylic acid derivative. _h[electronic resource] |
| 260 |
_bChemotherapy _c |
||
| 300 |
_a21-30 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAnti-Infective Agents _xpharmacokinetics |
| 650 | 0 | 4 | _aChromatography, Thin Layer |
| 650 | 0 | 4 |
_aDioxolanes _xmetabolism |
| 650 | 0 | 4 |
_aEscherichia coli _xdrug effects |
| 650 | 0 | 4 |
_aEscherichia coli Infections _xdrug therapy |
| 650 | 0 | 4 | _aFluoroquinolones |
| 650 | 0 | 4 | _aMacaca mulatta |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMice |
| 650 | 0 | 4 | _aMicrobial Sensitivity Tests |
| 650 | 0 | 4 |
_aPiperazines _xmetabolism |
| 650 | 0 | 4 |
_aProdrugs _xmetabolism |
| 650 | 0 | 4 |
_aPseudomonas Infections _xdrug therapy |
| 650 | 0 | 4 |
_aPseudomonas aeruginosa _xdrug effects |
| 650 | 0 | 4 |
_aQuinolones _xmetabolism |
| 650 | 0 | 4 |
_aStaphylococcal Infections _xdrug therapy |
| 650 | 0 | 4 |
_aStaphylococcus aureus _xdrug effects |
| 700 | 1 | _aTomii, Y | |
| 700 | 1 | _aMatsuda, M | |
| 700 | 1 | _aSegawa, J | |
| 700 | 1 | _aKitano, M | |
| 700 | 1 | _aKise, M | |
| 700 | 1 | _aNishino, T | |
| 773 | 0 |
_tChemotherapy _gvol. 44 _gno. 1 _gp. 21-30 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1159/000007086 _zAvailable from publisher's website |
| 999 |
_c9413632 _d9413632 |
||